Abstract
Type 2 diabetes rates continue to rise unabated, underscoring the need to better understand the etiology and potential therapeutic options available for this disease. The gut microbiome plays a role in glucose homeostasis, and diabetes is associated with alterations in the gut microbiome. Given that consumption of a Western diet is associated with increased metabolic disease, and that a Western diet alters the gut microbiome, it is plausible that changes in the gut microbiota mediate the dysregulation in glucose homeostasis. In this review, we highlight a few of the most significant mechanisms by which the gut microbiome can influence glucose regulation, including changes in gut permeability, gut-brain signaling, and production of bacteria-derived metabolites like short-chain fatty acids and bile acids. A better understanding of these pathways could lead to the development of novel therapeutics to target the gut microbiome in order to restore glucose homeostasis in metabolic disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 469-481 |
| Number of pages | 13 |
| Journal | Annual review of medicine |
| Volume | 73 |
| DOIs | |
| State | Published - 2022 |
| Externally published | Yes |
Keywords
- Bile acids
- Diabetes
- Gut microbiota
- High-fat diet
- Short-chain fatty acids
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology